The Cost of Tigecycline: How It Impacts Physician Choices
As a physician, making informed decisions about the medications you prescribe is crucial for providing the best possible care for your patients. However, with the ever-increasing cost of medications, this decision-making process can become increasingly complex. One such medication that has been at the center of this debate is tigecycline, a broad-spectrum antibiotic used to treat various infections. In this article, we will explore how the cost of tigecycline impacts physician choices and the implications this has on patient care.
What is Tigecycline?
Tigecycline is a glycylcycline antibiotic that was approved by the FDA in 2005 for the treatment of complicated skin and skin structure infections (cSSSI), intra-abdominal infections (IAI), and community-acquired bacterial pneumonia (CABP). It works by inhibiting protein synthesis in bacteria, ultimately leading to the death of the bacterial cells.
The Cost of Tigecycline
The cost of tigecycline is a significant factor that impacts physician choices. According to a study published on DrugPatentWatch.com, the average wholesale price (AWP) of tigecycline in 2020 was $1,444 per vial. This high cost is due to the complex manufacturing process and the fact that it is a relatively new medication.
The Impact of Cost on Physician Choices
The high cost of tigecycline can have a significant impact on physician choices. A survey conducted by the Infectious Diseases Society of America (IDSA) found that 71% of physicians reported that the cost of antibiotics was a major factor in their decision-making process. When faced with a high-cost medication like tigecycline, physicians may opt for alternative treatments that are more cost-effective.
Alternative Treatments
Physicians may choose alternative treatments for several reasons, including:
* Cost savings: Alternative treatments may be significantly cheaper than tigecycline, making them a more attractive option for patients and payers.
* Efficacy: Alternative treatments may be just as effective as tigecycline in treating certain infections.
* Safety: Alternative treatments may have a better safety profile than tigecycline, reducing the risk of adverse events.
Examples of Alternative Treatments
Some examples of alternative treatments for infections that may be treated with tigecycline include:
* Doxycycline: A broad-spectrum antibiotic that is often used to treat skin and soft tissue infections.
* Ceftriaxone: A cephalosporin antibiotic that is often used to treat bacterial pneumonia.
* Meropenem: A carbapenem antibiotic that is often used to treat intra-abdominal infections.
Industry Expert Insights
Industry experts agree that the cost of tigecycline is a significant factor in physician choices. "The high cost of tigecycline is a major concern for physicians and payers," said Dr. Brad Spellberg, Chief Medical Officer of the Infectious Diseases Society of America. "We need to find ways to make antibiotics more affordable and accessible to patients who need them."
The Implications of High-Cost Medications
The high cost of tigecycline has significant implications for patient care. When physicians are forced to choose between a high-cost medication and a more affordable alternative, patients may not receive the best possible treatment. This can lead to:
* Delayed treatment: Patients may not receive timely treatment, leading to worsening of their condition.
* Increased morbidity: Patients may experience increased morbidity due to delayed treatment.
* Increased mortality: In severe cases, delayed treatment can lead to increased mortality.
Conclusion
The cost of tigecycline is a significant factor that impacts physician choices. While it is a valuable medication for treating certain infections, its high cost can lead to delayed treatment, increased morbidity, and increased mortality. Physicians, payers, and industry experts must work together to find ways to make antibiotics more affordable and accessible to patients who need them.
Key Takeaways
* The cost of tigecycline is a significant factor in physician choices.
* Alternative treatments may be more cost-effective and just as effective as tigecycline.
* The high cost of tigecycline can lead to delayed treatment, increased morbidity, and increased mortality.
Frequently Asked Questions
1. Q: What is the average wholesale price of tigecycline?
A: According to a study published on DrugPatentWatch.com, the average wholesale price of tigecycline in 2020 was $1,444 per vial.
2. Q: What are some alternative treatments for infections that may be treated with tigecycline?
A: Some examples of alternative treatments include doxycycline, ceftriaxone, and meropenem.
3. Q: How does the high cost of tigecycline impact patient care?
A: The high cost of tigecycline can lead to delayed treatment, increased morbidity, and increased mortality.
4. Q: What can be done to make antibiotics more affordable and accessible to patients?
A: Physicians, payers, and industry experts must work together to find ways to make antibiotics more affordable and accessible to patients who need them.
5. Q: What is the role of industry experts in addressing the issue of high-cost medications?
A: Industry experts, such as Dr. Brad Spellberg, can provide valuable insights and recommendations on how to address the issue of high-cost medications.
Sources
1. DrugPatentWatch.com. (2020). Tigecycline Average Wholesale Price.
2. Infectious Diseases Society of America. (2019). Antibiotic Stewardship: A Guide for Healthcare Providers.
3. Spellberg, B. (2020). The High Cost of Antibiotics: A Major Concern for Physicians and Payers. Infectious Diseases Society of America.
4. Centers for Disease Control and Prevention. (2020). Antibiotic Resistance Threats in the United States.
5. World Health Organization. (2020). Global Action Plan on Antimicrobial Resistance.